Navigation Links
Ganeden Biotech® Moves Its State-Of-The-Art Lab To Its World Headquarters In Cleveland
Date:1/15/2013

Cleveland, OH (PRWEB) January 15, 2013

Ganeden Biotech®, a recognized world leader in the manufacturing and marketing of probiotics, announces that its state-of-the-art lab has been moved to its world headquarters in Mayfield Heights, OH.

The company relocated its multi-million dollar lab from Miami to its Cleveland headquarters so that partners and customers could take best advantage of resources in a single facility.

The company’s state-of-the-art research and development facility is one of the most advanced probiotic technological research laboratories in the world. Guided by Lead Scientist, Dr. Howard Cash, the R&D organization has capabilities ranging from strain selection and genetic identification to product development support and stability testing. By working in partnership with licensees, Ganeden’s research team works to ensure the most stable, efficacious probiotic products available.

“Ganeden's lab facility enables us to serve as an R&D resource for our partners and clients. Through the use of our lab, our clients are able to bring top quality, well-researched products to market in a very short period of time,” said Mike Bush, Vice President, Business Development. “We are able to provide services ranging from formulation assistance, enumeration, stress testing, genetic sequencing and process refinement - all at no cost to our partners and clients.”

Ganeden’s 4,000 square-foot facility features an array of state of the art equipment including the 3130 Genetic Analyzer from Applied Biosystems and the 2100 Bioanalyzer from Agilent Technologies, which allow for verification of each lot of GanedenBC30 by PCR and genetic sequencing.

“In addition to the standard freezers, refrigerators, sterilizers, freeze dryers, incubators and bio-safety hoods typically found in a modern microbiology lab, we also have a full kitchen area used for preparing our customer’s products as a final consumer would do, before we test for viability of GanedenBC30,” Dr. Cash said.

GanedenBC30 can currently be found in more than 60 foods and beverage products including: baked goods, refrigerated beverages, drink mixes, prepared foods, milk and yogurt, confectionary products, nutrition bars and meal replacement powders.

“When we decided to invest in a lab expansion 7 years ago, we decided to invest in only the very best technologies so that our partners and clients would have access to state of the art resources. We are happy that they can now access this, along with all of Ganeden’s other resources, in a single location,” Bush said.

About Ganeden Biotech

Founded in 1997, Cleveland, Ohio based Ganeden Biotech is at the forefront of probiotic research and product development. Ganeden has an extensive library of published studies and more than 100 issued patents for probiotic technologies for the food, beverage, animal health, and now topical ingredients markets. The company is best known for GanedenBC30, its patented, probiotic ingredient, which is found in more than 60 leading food and beverage products. Ganeden helps manufacturers develop and market probiotic products and offers an extensive intellectual property portfolio with patent and trademark protection for an array of technologies all over the world.
For more information about Ganeden Biotech and licensing opportunities, visit ganedenbiotech.com.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10322412.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Probiotic-Enriched Instant Chai Latte and Teas to be Launched by Ganeden Biotech and Tipton Mills
2. Ganeden Biotech Hires New Marketing Manager
3. Cord Blood America Announces DTCC Removes "Chill" Imposed in December 2010
4. Tiny levers, big moves in piezoelectric sensors
5. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
6. Graphene electronics moves into a third dimension
7. New imaging technique moves from lab to clinic
8. Instrumentation Laboratory Moves To Direct Distribution Of Hemostasis Product Line In North America
9. Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
10. State-of-the-Art Novelda NVA6000 Impulse Radar Transceiver Finds Widespread Appeal and Applications
11. Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Ind. , Dec. 6, 2016 Zimmer ... "Company") today announced the pricing terms of its ... to $1.25 billion aggregate purchase price (excluding accrued and ... settlement date and excluding fees and expenses related ... the debt securities identified in the table below ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... company focused on discovery and development of precision treatments for neurodegenerative diseases, ... for Alzheimer’s disease (AD) inhibited the direct neurotoxic effect of prion-like forms ...
(Date:12/5/2016)... ... 05, 2016 , ... This composition patent, U.S. Patent No. ... The composition claims are not limited to any particular process to make or ... carbon fibers, graphene, and other materials. A continuation application, U.S. Patent App. ...
(Date:12/5/2016)... ... ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in ... Lubinski will be traveling to Germany on December 6th. Mr. Lubinski will meet ... discuss the benefits of a viscoelastic total disc replacement. , AxioMed received its ...
Breaking Biology Technology:
(Date:12/6/2016)... Valencell , the leading innovator in ... a third consecutive year of triple digit growth for ... with a 360 percent increase in companies who have ... driven by sales of its wrist and ear Benchmark™ ... technology for hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... India , December 1, 2016 ... Authentication type (Fingerprint, Voice), Future Technology (Iris Recognition ... and Region - Global Forecast to 2021", published ... USD 442.7 Million in 2016, and is projected ... at a CAGR of 14.06%.      ...
(Date:11/30/2016)...  higi SH llc (higi) announced today the ... brands, industry thought-leaders and celebrity influencers looking to ... taking steps to live healthier, more active lives. ... has built the largest self-screening health station network ... who have conducted over 185 million biometric screenings.  ...
Breaking Biology News(10 mins):